Product information and disease descriptionProduct descriptionProduct information
Special populations
5 evidence topics · 4 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct descriptionProduct information
5 evidence topics · 4 sources